These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 33359485)

  • 21. The Epigenomic Landscape in Osteoarthritis.
    Simon TC; Jeffries MA
    Curr Rheumatol Rep; 2017 Jun; 19(6):30. PubMed ID: 28456906
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aberrant epigenetic landscape in cancer: how cellular identity goes awry.
    Berdasco M; Esteller M
    Dev Cell; 2010 Nov; 19(5):698-711. PubMed ID: 21074720
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Roadmap for investigating epigenome deregulation and environmental origins of cancer.
    Herceg Z; Ghantous A; Wild CP; Sklias A; Casati L; Duthie SJ; Fry R; Issa JP; Kellermayer R; Koturbash I; Kondo Y; Lepeule J; Lima SCS; Marsit CJ; Rakyan V; Saffery R; Taylor JA; Teschendorff AE; Ushijima T; Vineis P; Walker CL; Waterland RA; Wiemels J; Ambatipudi S; Degli Esposti D; Hernandez-Vargas H
    Int J Cancer; 2018 Mar; 142(5):874-882. PubMed ID: 28836271
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epigenetic dysregulation in autophagy signaling as a driver of viral manifested oral carcinogenesis.
    Patra S; Patil S; Das S; Bhutia SK
    Biochim Biophys Acta Mol Basis Dis; 2022 Nov; 1868(11):166517. PubMed ID: 35940381
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New Promises to Cure Cancer and Other Genetic Diseases/Disorders: Epi-drugs Through Epigenetics.
    Duan YT; Sangani CB; Liu W; Soni KV; Yao Y
    Curr Top Med Chem; 2019; 19(12):972-994. PubMed ID: 31161992
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Investigation of epigenetics in kidney cell biology.
    Li LX; Agborbesong E; Zhang L; Li X
    Methods Cell Biol; 2019; 153():255-278. PubMed ID: 31395383
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Compendium of aberrant DNA methylation and histone modifications in cancer.
    Hattori N; Ushijima T
    Biochem Biophys Res Commun; 2014 Dec; 455(1-2):3-9. PubMed ID: 25194808
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Current and upcoming approaches to exploit the reversibility of epigenetic mutations in breast cancer.
    Falahi F; van Kruchten M; Martinet N; Hospers GA; Rots MG
    Breast Cancer Res; 2014 Jul; 16(4):412. PubMed ID: 25410383
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Advances of Epigenetic Biomarkers and Epigenome Editing for Early Diagnosis in Breast Cancer.
    Sarvari P; Sarvari P; Ramírez-Díaz I; Mahjoubi F; Rubio K
    Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36076918
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeting the epigenome in malignant melanoma: Facts, challenges and therapeutic promises.
    Anestopoulos I; Kyriakou S; Tragkola V; Paraskevaidis I; Tzika E; Mitsiogianni M; Deligiorgi MV; Petrakis G; Trafalis DT; Botaitis S; Giatromanolaki A; Koukourakis MI; Franco R; Pappa A; Panayiotidis MI
    Pharmacol Ther; 2022 Dec; 240():108301. PubMed ID: 36283453
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Progress and promises of epigenetic drugs and epigenetic diets in cancer prevention and therapy: A clinical update.
    Mondal P; Natesh J; Penta D; Meeran SM
    Semin Cancer Biol; 2022 Aug; 83():503-522. PubMed ID: 33309850
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Epigenomic Revolution in Breast Cancer: From Single-Gene to Genome-Wide Next-Generation Approaches.
    Davalos V; Martinez-Cardus A; Esteller M
    Am J Pathol; 2017 Oct; 187(10):2163-2174. PubMed ID: 28734945
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Single-cell epigenomics in cancer: charting a course to clinical impact.
    Bond DR; Uddipto K; Enjeti AK; Lee HJ
    Epigenomics; 2020 Jul; 12(13):1139-1151. PubMed ID: 32790506
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epigenetic modifications in multiple myeloma: recent advances on the role of DNA and histone methylation.
    Amodio N; D'Aquila P; Passarino G; Tassone P; Bellizzi D
    Expert Opin Ther Targets; 2017 Jan; 21(1):91-101. PubMed ID: 27892767
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Getting personal with epigenetics: towards individual-specific epigenomic imputation with machine learning.
    Hawkins-Hooker A; Visonà G; Narendra T; Rojas-Carulla M; Schölkopf B; Schweikert G
    Nat Commun; 2023 Aug; 14(1):4750. PubMed ID: 37550323
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuroblastoma and the epigenome.
    Fetahu IS; Taschner-Mandl S
    Cancer Metastasis Rev; 2021 Mar; 40(1):173-189. PubMed ID: 33404859
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The gymnastics of epigenomics in rice.
    Banerjee A; Roychoudhury A
    Plant Cell Rep; 2018 Jan; 37(1):25-49. PubMed ID: 28866772
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epigenetics and cancer, 2nd IARC meeting, Lyon, France, 6 and 7 December 2007.
    Lambert MP; Herceg Z
    Mol Oncol; 2008 Jun; 2(1):33-40. PubMed ID: 19383327
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genome-wide epigenetic modifications in cancer.
    Park YJ; Claus R; Weichenhan D; Plass C
    Prog Drug Res; 2011; 67():25-49. PubMed ID: 21141723
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analyzing DNA Methylation Patterns During Tumor Evolution.
    Pan H; Elemento O
    Methods Mol Biol; 2018; 1711():27-53. PubMed ID: 29344884
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.